Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Breast Cancer”

171 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 171 results

Not applicableLooking for participantsNCT06813456
What this trial is testing

Implementation of Solid Digital PCR to Support Gold-standard Methods for Evaluation of HER2 Amplification Status: Focus on HER2-low Subtype

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 234
Not applicableStudy completedNCT03121469
What this trial is testing

Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer

Who this might be right for
Localized Breast Cancer
Centre Antoine Lacassagne 28
Very early researchStudy completedNCT03542695
What this trial is testing

64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy

Who this might be right for
Breast CarcinomaCalcification
City of Hope Medical Center 1
Not applicableStudy completedNCT01834950
What this trial is testing

Identification of Early Markers of Response and Resistance to Trastuzumab

Who this might be right for
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 25
Large-scale testing (Phase 3)Study completedNCT00256698
What this trial is testing

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

Who this might be right for
Breast Cancer
AstraZeneca 514
Early research (Phase 1)UnknownNCT03749850
What this trial is testing

Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer

Who this might be right for
Metastatic Breast CancerBreast CancerBreast Neoplasms+5 more
UMC Utrecht 12
Not applicableLooking for participantsNCT06027632
What this trial is testing

Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer

Who this might be right for
Breast CancerCognitive Dysfunction
Centre Francois Baclesse 300
Not applicableLooking for participantsNCT07264998
What this trial is testing

Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea

Who this might be right for
Breast NeoplasmsHormone Receptor-Positive Breast CancerAbemaciclib+4 more
Hubei Cancer Hospital 60
Not applicableStudy completedNCT04066361
What this trial is testing

OPTimizing Treatment Focused Genetic Testing IN Cancer

Who this might be right for
Breast CancerOvarian CancerPancreatic Cancer+1 more
Dana-Farber Cancer Institute 301
Not applicableLooking for participantsNCT07067138
What this trial is testing

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Who this might be right for
Breast CancerBreast CarcinomaCancer of the Breast+1 more
National Cancer Institute (NCI) 175
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Very early researchLooking for participantsNCT05291507
What this trial is testing

Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System

Who this might be right for
Breast Cancer
University of Utah 34
Not applicableLooking for participantsNCT03463954
What this trial is testing

Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

Who this might be right for
Malignant Neoplasm of Breast
Novian Health Inc. 122
Not applicableStudy completedNCT04397185
What this trial is testing

Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer

Who this might be right for
Breast Cancer Female
CairnSurgical, Inc. 480
Not applicableStudy completedNCT02300675
What this trial is testing

Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy

Who this might be right for
Breast Cancer
Institut de Cancérologie de la Loire 352
Early research (Phase 1)Ended earlyNCT06130254
What this trial is testing

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

Who this might be right for
Advanced Solid TumorNon-small Cell Lung Cancers
M.D. Anderson Cancer Center 1
Large-scale testing (Phase 3)Study completedNCT00022087
What this trial is testing

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Alliance for Clinical Trials in Oncology 439
Not applicableUnknownNCT01541878
What this trial is testing

Breast Cancer Registry in Thailand

Who this might be right for
Conditions or Focus of Study: *FDAAA(Enter 1 to 5 Items)
Siriraj Hospital 300
Post-approval studies (Phase 4)Looking for participantsNCT05362760
What this trial is testing

Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management

Who this might be right for
Hormone Receptor-positive Metastatic Breast CancerHER2-negative Metastatic Breast Cancer
Prof. Wolfgang Janni 300
Not applicableLooking for participantsNCT06991946
What this trial is testing

Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain

Who this might be right for
Metastatic Breast Cancer
SOLTI Breast Cancer Research Group 300
Load More Results